InVitria stem cell technology to be highlighted in Journal of Biotechnology
FORT COLLINS - InVitria , a division of Ventria Bioscience , announced the publication of new research demonstrating InVitria's animal-component-free recombinant human leukemia inhibitory factor... Read More
Tuesday January 7, 2014 0 comments
Ventria Bioscience, USC to collaborate on cost-effective diabetes treatment research
FORT COLLINS - Ventria Bioscience and the University of Southern California have been awarded a Small Business Innovation Research grant from the National Institutes of Health to develop a... Read More
Wednesday February 13, 2013 0 comments
Ventria's Optiferrin shown functionally comparable to human transferrin in published study
FORT COLLINS - Ventria Bioscience's Optiferrin recombinant human transferrin has been shown functionally comparable to purified human transferrin in a study just published by the journal BMC... Read More
Friday December 14, 2012 0 comments
Ventria Bioscience acquires Meristem Therapeutics' Recombinant Lactoferrin IP
FORT COLLINS - Ventria Bioscience will wholly acquire portions of the intellectual property portfolio relating to Recombinant Lactoferrin developed by the French biotech company Meristem... Read More
Tuesday December 4, 2012 0 comments
Ventria Bioscience: Study shows Optiferrin is comparable to human transferrin
FORT COLLINS - Ventria Bioscience announced that its Optiferrin product has been shown to be biochemically and structurally similar to human transferrin molecules derived from human serum or a... Read More
Tuesday October 9, 2012 0 comments
Ventria Bioscience and UC-Denver awarded grant to study acetaminophen overdose-induced liver failure
FORT COLLINS - Ventria Bioscience has received notification of approximately $200,000 in funding for a research proposal to study treatment of acetaminophen overdose-induced liver failure,... Read More
Tuesday September 4, 2012 0 comments
InVitria receives $1.5 million grant for cell-based vaccines
FORT COLLINS - InVitria, a division of Ventria Bioscience, announced it will receive $1.5 million over two years to develop a novel, animal-free, defined cell culture media for the commercial... Read More
Wednesday May 30, 2012 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
